Tianning Gu

515 total citations
14 papers, 266 citations indexed

About

Tianning Gu is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Tianning Gu has authored 14 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Tianning Gu's work include CAR-T cell therapy research (9 papers), Virus-based gene therapy research (4 papers) and Biomedical Ethics and Regulation (2 papers). Tianning Gu is often cited by papers focused on CAR-T cell therapy research (9 papers), Virus-based gene therapy research (4 papers) and Biomedical Ethics and Regulation (2 papers). Tianning Gu collaborates with scholars based in China. Tianning Gu's co-authors include He Huang, Yongxian Hu, Xiaohui Si, Meng Zhu, Pengxu Qian, Yingli Han, Xiu‐Jian Wang, Yue Huang, Kejia Hu and Delin Kong and has published in prestigious journals such as Blood, The FASEB Journal and Cellular and Molecular Life Sciences.

In The Last Decade

Tianning Gu

13 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tianning Gu China	9	166	119	66	47	46	14	266
Chengfei Pu China	8	202 1.2×	87 0.7×	96 1.5×	60 1.3×	28 0.6×	19	277
Alexander Tepper United States	5	170 1.0×	122 1.0×	59 0.9×	48 1.0×	71 1.5×	6	268
Katerina Goudevenou United Kingdom	5	217 1.3×	92 0.8×	165 2.5×	31 0.7×	23 0.5×	10	298
Sagar L. Patil United States	6	140 0.8×	103 0.9×	60 0.9×	42 0.9×	36 0.8×	8	207
Tommaso Sconocchia Austria	10	116 0.7×	86 0.7×	91 1.4×	22 0.5×	43 0.9×	20	252
Ziran Zhao United States	6	131 0.8×	151 1.3×	38 0.6×	29 0.6×	39 0.8×	9	227
Sanaz Taromi Germany	9	305 1.8×	156 1.3×	139 2.1×	62 1.3×	77 1.7×	13	422
Steven Tsai United States	8	166 1.0×	151 1.3×	84 1.3×	33 0.7×	39 0.8×	14	308
Xia Han United States	4	269 1.6×	121 1.0×	64 1.0×	69 1.5×	64 1.4×	8	312
Jaquelyn T. Zoine United States	9	203 1.2×	79 0.7×	116 1.8×	47 1.0×	48 1.0×	12	266

Countries citing papers authored by Tianning Gu

Since Specialization

Citations

This map shows the geographic impact of Tianning Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianning Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianning Gu more than expected).

Fields of papers citing papers by Tianning Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianning Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianning Gu. The network helps show where Tianning Gu may publish in the future.

Co-authorship network of co-authors of Tianning Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Tianning Gu. A scholar is included among the top collaborators of Tianning Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianning Gu. Tianning Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Gu, Tianning, et al.. (2025). Synergistic therapy of Chinese herbal medicine and gut microbiota modulation for post-stroke cognitive recovery: focus on microbial metabolite and immunoinflammation. Frontiers in Microbiology. 16. 1623843–1623843. 1 indexed citations

Zhu, Meng, Yingli Han, Tianning Gu, et al.. (2024). Class I HDAC inhibitors enhance antitumor efficacy and persistence of CAR-T cells by activation of the Wnt pathway. Cell Reports. 43(4). 114065–114065. 39 indexed citations

Gu, Tianning, et al.. (2024). How can we improve the successful identification of patients suitable for CAR-T cell therapy?. Expert Review of Molecular Diagnostics. 24(9). 777–792.

Zhu, Meng, Qiwei Wang, Tianning Gu, et al.. (2023). Hydrogel-based microenvironment engineering of haematopoietic stem cells. Cellular and Molecular Life Sciences. 80(2). 49–49. 8 indexed citations

Gu, Tianning, Meng Zhu, Yingli Han, et al.. (2023). Epigenetic Reprogramming By Histone Deacetylase Inhibitors Improves CAR-T Cell Functions. Blood. 142(Supplement 1). 2080–2080. 2 indexed citations

Hu, Yongxian, Tianning Gu, Linqin Wang, et al.. (2022). CAR T-cell therapies in China: rapid evolution and a bright future. The Lancet Haematology. 9(12). e930–e941. 32 indexed citations

Gu, Tianning, Meng Zhu, He Huang, & Yongxian Hu. (2022). Relapse after CAR-T cell therapy in B-cell malignancies: challenges and future approaches. Journal of Zhejiang University SCIENCE B. 23(10). 793–811. 24 indexed citations

Si, Xiaohui, Tianning Gu, Yue Huang, et al.. (2022). Hematologic cytopenia post CAR T cell therapy: Etiology, potential mechanisms and perspective. Cancer Letters. 550. 215920–215920. 19 indexed citations

Gu, Tianning, et al.. (2022). Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting. Experimental Hematology and Oncology. 11(1). 61–61. 12 indexed citations

10.

Shao, Mi, Xinyi Teng, Xin Guo, et al.. (2022). Inhibition of Calcium Signaling Prevents Exhaustion and Enhances Anti‐Leukemia Efficacy of CAR‐T Cells via SOCE‐Calcineurin‐NFAT and Glycolysis Pathways. Advanced Science. 9(9). e2103508–e2103508. 44 indexed citations

11.

Gu, Tianning, Kejia Hu, Xiaohui Si, Yongxian Hu, & He Huang. (2022). Mechanisms of immune effector cell‐associated neurotoxicity syndrome after CAR‐T treatment. PubMed. 14(6). e1576–e1576. 26 indexed citations

12.

Gao, Yang, Wei Shan, Tianning Gu, et al.. (2021). Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration. Frontiers in Immunology. 12. 785774–785774. 5 indexed citations

13.

Gu, Tianning, et al.. (2021). [Programmed death ligand 1 expression and CD8⁺T lymphocyte infiltration in salivary gland lymphoepithelial carcinoma].. PubMed. 50(11). 1222–1227. 1 indexed citations

14.

Yang, Li, Qiang Sun, Mingchun Jiang, et al.. (2019). KLF9 suppresses gastric cancer cell invasion and metastasis through transcriptional inhibition of MMP28. The FASEB Journal. 33(7). 7915–7928. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact